{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ04637",
      "entity_text" : "VII.5\n\n\nRecombinant factor VII",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "interpro:IPR003966",
      "entity_text" : "thrombin",
      "entity_type" : "family"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Then, thrombin triggers platelet activation and consequently factors V and VII.5 Recombinant factor VII activated (rFVIIa) is an agent approved in both hemophilia A and B patients, factor VII deficiency, and Glanzmann 's thrombasthenia.6 It has also been used in several surgical conditions to stop persistent bleeding in patients without inherited coagulopathies.6 We report the case of a man with amyotrophic lateral sclerosis (ALS) admitted to our general intensive care unit (ICU) for respiratory failure and presenting a late postprocedural bleeding after 36 hours from PDT due to thrombocytopenia.",
  "reading_complete" : "2020-08-03T15:03:31Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T15:03:02Z",
  "trigger" : "triggers",
  "evidence" : [ "thrombin triggers platelet activation and consequently factors V and VII.5\n\n\nRecombinant factor VII" ],
  "pmc_id" : "6452479",
  "score" : 0
}